AtheroNova Inc. Appoints Dr. Randolph M. Johnson As Chief Operating Officer
IRVINE, Calif., April 8, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Randolph M. Johnson, Ph.D. has joined the Company as Chief Operating Officer.
Help employers find you! Check out all the jobs and post your resume.